Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2005 1
2008 1
2009 1
2010 2
2011 4
2012 2
2013 3
2014 8
2015 10
2016 13
2017 13
2018 14
2019 9
2020 13
2021 15
2022 9
2023 18
2024 11

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Results by year

Filters applied: . Clear all
Page 1
Microbial foods for improving human and planetary health.
Jahn LJ, Rekdal VM, Sommer MOA. Jahn LJ, et al. Among authors: sommer moa. Cell. 2023 Feb 2;186(3):469-478. doi: 10.1016/j.cell.2022.12.002. Epub 2023 Jan 18. Cell. 2023. PMID: 36657442 Free article. Review.
Engineered phage with antibacterial CRISPR-Cas selectively reduce E. coli burden in mice.
Gencay YE, Jasinskytė D, Robert C, Semsey S, Martínez V, Petersen AØ, Brunner K, de Santiago Torio A, Salazar A, Turcu IC, Eriksen MK, Koval L, Takos A, Pascal R, Schou TS, Bayer L, Bryde T, Johansen KC, Bak EG, Smrekar F, Doyle TB, Satlin MJ, Gram A, Carvalho J, Jessen L, Hallström B, Hink J, Damholt B, Troy A, Grove M, Clube J, Grøndahl C, Haaber JK, van der Helm E, Zdravkovic M, Sommer MOA. Gencay YE, et al. Among authors: sommer moa. Nat Biotechnol. 2024 Feb;42(2):265-274. doi: 10.1038/s41587-023-01759-y. Epub 2023 May 4. Nat Biotechnol. 2024. PMID: 37142704 Free PMC article.
Orismilast in moderate-to-severe psoriasis: Efficacy and safety from a 16-week, randomized, double-blinded, placebo-controlled, dose-finding, and phase 2b trial (IASOS).
Warren RB, French LE, Blauvelt A, Langley RG, Egeberg A, Mrowietz U, Hunter HJA, Gooderham M, Soerensen P, Andres P, Sommer MOA, Carlsson A, Kjøller KD, Strober BE. Warren RB, et al. Among authors: sommer moa. J Am Acad Dermatol. 2024 Mar;90(3):494-503. doi: 10.1016/j.jaad.2023.11.005. Epub 2023 Nov 10. J Am Acad Dermatol. 2024. PMID: 37951245 Free article. Clinical Trial.
Wiring cell growth to product formation.
Buerger J, Gronenberg LS, Genee HJ, Sommer MOA. Buerger J, et al. Among authors: sommer moa. Curr Opin Biotechnol. 2019 Oct;59:85-92. doi: 10.1016/j.copbio.2019.02.014. Epub 2019 Mar 28. Curr Opin Biotechnol. 2019. PMID: 30928842 Free article. Review.
Pharmacology of orismilast, a potent and selective PDE4 inhibitor.
Silverberg JI, French LE, Warren RB, Strober B, Kjøller K, Sommer MOA, Andres P, Felding J, Weiss A, Tutkunkardas D, Skak-Nielsen T, Guttman E. Silverberg JI, et al. Among authors: sommer moa. J Eur Acad Dermatol Venereol. 2023 Apr;37(4):721-729. doi: 10.1111/jdv.18818. Epub 2023 Jan 18. J Eur Acad Dermatol Venereol. 2023. PMID: 36527389
Antibiotics and the resistant microbiome.
Sommer MO, Dantas G. Sommer MO, et al. Curr Opin Microbiol. 2011 Oct;14(5):556-63. doi: 10.1016/j.mib.2011.07.005. Epub 2011 Jul 27. Curr Opin Microbiol. 2011. PMID: 21802347 Review.
Bacterial resistance to CRISPR-Cas antimicrobials.
Uribe RV, Rathmer C, Jahn LJ, Ellabaan MMH, Li SS, Sommer MOA. Uribe RV, et al. Among authors: sommer moa. Sci Rep. 2021 Aug 26;11(1):17267. doi: 10.1038/s41598-021-96735-4. Sci Rep. 2021. PMID: 34446818 Free PMC article.
140 results